We are live on ! Find out more
NAP

New Amsterdam Partners Portfolio holdings

AUM $272M
1-Year Est. Return 12.21%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+12.21%
3 Year Est. Return
+73.94%
5 Year Est. Return
+120.95%
10 Year Est. Return
AUM
$479M
AUM Growth
+$8.17M
Cap. Flow
-$15.5M
Cap. Flow %
-3.23%
Top 10 Hldgs %
24.9%
Holding
136
New
20
Increased
25
Reduced
60
Closed
19

Top Buys

Rank Stock Value
1
ORA icon
Ormat Technologies
ORA
+$6.31M
2
CNS icon
Cohen & Steers
CNS
+$6.06M
3
AGX icon
Argan
AGX
+$5.05M
4
EPC icon
Edgewell Personal Care
EPC
+$4.61M
5
SAM icon
Boston Beer
SAM
+$4.37M

Top Sells

Rank Stock Value
1
PRI icon
Primerica
PRI
+$10.3M
2
SR icon
Spire
SR
+$7.78M
3
INGR icon
Ingredion
INGR
+$5.62M
4
DORM icon
Dorman Products
DORM
+$4.97M
5
GPRE icon
Green Plains
GPRE
+$4.94M

Sector Composition

Rank Sector Weight
1 Industrials 17.81%
2 Consumer Discretionary 17.44%
3 Technology 16.25%
4 Financials 13%
5 Healthcare 10.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQIX icon
101
Equinix
EQIX
$103B
$496K 0.1%
1,111
+540
+95% +$242K
FAST icon
102
Fastenal
FAST
$57.1B
$481K 0.1%
+42,176
New +$454K
JBLU icon
103
JetBlue
JBLU
$1.81B
$471K 0.1%
25,445
BIIB icon
104
Biogen
BIIB
$32.3B
$461K 0.1%
1,471
BWA icon
105
BorgWarner
BWA
$13.1B
$454K 0.09%
+10,062
New +$411K
LH icon
106
Labcorp
LH
$27.2B
$442K 0.09%
3,412
-1,066
-24% -$142K
CTXS
107
DELISTED
Citrix Systems Inc
CTXS
$375K 0.08%
4,879
+1,979
+68% +$154K
HAIN icon
108
Hain Celestial
HAIN
$65.9M
$353K 0.07%
8,581
EW icon
109
Edwards Lifesciences
EW
$52B
$317K 0.07%
8,703
+654
+8% +$24.9K
SYF icon
110
Synchrony
SYF
$25.4B
$303K 0.06%
+9,751
New +$292K
LULU icon
111
lululemon athletica
LULU
$13.7B
$297K 0.06%
4,778
-27,619
-85% -$1.66M
CHRW icon
112
C.H. Robinson
CHRW
$17.6B
$258K 0.05%
3,394
-2,450
-42% -$170K
FFIV icon
113
F5
FFIV
$22.3B
$252K 0.05%
2,090
-2,060
-50% -$249K
ORLY icon
114
O'Reilly Automotive
ORLY
$71.6B
$220K 0.05%
+15,345
New +$203K
SBNY
115
DELISTED
Signature Bank
SBNY
$215K 0.04%
1,680
-28
-2% -$3.68K
JLL icon
116
Jones Lang LaSalle
JLL
$17.4B
$206K 0.04%
1,668
-1,784
-52% -$221K
BFH icon
117
Bread Financial
BFH
$4.06B
$202K 0.04%
1,140
AMT icon
118
American Tower
AMT
$82.1B
-3,855
Closed -$510K
ATRO icon
119
Astronics
ATRO
$3.26B
-100,922
Closed -$2.23M
CARS icon
120
Cars.com
CARS
$639M
-69,827
Closed -$1.86M
CRS icon
121
Carpenter Technology
CRS
$23.6B
-70,129
Closed -$2.63M
DFS
122
DELISTED
Discover Financial Services
DFS
-5,043
Closed -$314K
DORM icon
123
Dorman Products
DORM
$3.84B
-60,065
Closed -$4.97M
EHC icon
124
Encompass Health
EHC
$11.9B
-35,412
Closed -$1.36M
GPK icon
125
Graphic Packaging
GPK
$3.42B
-202,836
Closed -$2.79M

Similar funds

New Amsterdam Partners's Q3 2017 Portfolio in Review

As of Q3 2017, New Amsterdam Partners held 136 positions worth $479M, up 1.7% from $470M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

New Amsterdam Partners withdrew a net $15.5M in Q3 2017, closing 19 positions and reducing 60 holdings. Its most notable exit was Primerica, an estimated $10.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, New Amsterdam Partners opened a new position in Ormat Technologies worth $6.68M.

  • New Amsterdam Partners's largest Q3 2017 buy was Ormat Technologies: 109,368 shares worth $6.68M.
  • New Amsterdam Partners added most to American Equity Investment Life Holding Company in Q3 2017, an estimated $4.2M increase.
  • New Amsterdam Partners's biggest Q3 2017 reduction was Ingredion, cutting an estimated $5.62M.
  • New Amsterdam Partners fully exited Primerica in Q3 2017, selling an estimated $10.3M.
  • New Amsterdam Partners's ten largest holdings make up 25% of its $479M portfolio in Q3 2017.
  • New Amsterdam Partners opened 20 new positions and closed 19 in Q3 2017.
  • New Amsterdam Partners's portfolio value rose 1.7% quarter-over-quarter to $479M.

Based on New Amsterdam Partners's 13F filing for Q3 2017, filed 2 Nov 2017.